SECNIDAZOLE | SECNIDAZOLE | ATC P01AB07 ATC J01RA07
ANTIPARASITIC A NITROIMIDAZOLE ANTIMICROBIAL TREATMENT OF BACTERIAL VAGINOSIS IN ADULT WOMEN 5-NITROIMIDAZOLES ENTER THE BACTERIAL CELL AS AN INACTIVE PRODRUG WHERE THE NITRO GROUP IS REDUCED BY BACTERIAL ENZYMES TO RADICAL ANIONS. IT IS BELIEVED THAT THESE RADICAL ANIONS INTERFERE WITH BACTERIAL DNA SYNTHESIS OF SUSCEPTIBLE ISOLATES | ORAL | Cmax 245.3 MICROMOLAR Tmax 4 HOUR VD 42 LITER PPB 5 PERCENT Cl 1.5 LITER / HOUR HT 17 HOUR | DNA | 3-oxoacyl-[acyl-carrier-protein] synthase 3 C3TDZ2 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |